{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:16Z","timestamp":1761896476651},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.acuro.2016.12.004","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T09:31:20Z","timestamp":1487669480000},"page":"17-24","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Indicaci\u00f3n de cistectom\u00eda precoz en el c\u00e1ncer vesical no m\u00fasculo infiltrante. Revisi\u00f3n de la literatura"],"prefix":"10.1016","volume":"42","author":[{"given":"L.","family":"Cogorno Wasylkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"R\u00edos-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Linares Espin\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leibar Tamayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez-Pi\u00f1eiro Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2016.12.004_bib0155","series-title":"Non-muscle-invasive bladder cancer (Ta, T1 and CIS)","first-page":"1","author":"Babjuk*","year":"2016"},{"key":"10.1016\/j.acuro.2016.12.004_bib0160","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester**","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non\u2013muscle-invasive stage Ta\u2013T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guerin","volume":"69","author":"Cambier*","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0170","first-page":"466","volume":"49","author":"Sylvester","year":"2006","journal-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2,596 patients from seven EORTC trials"},{"key":"10.1016\/j.acuro.2016.12.004_bib0175","first-page":"2195","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model","volume":"182","author":"Fernandez-Gomez**","year":"2009","journal-title":"JURO"},{"key":"10.1016\/j.acuro.2016.12.004_bib0180","first-page":"238","volume":"68","author":"Kluth","year":"2015","journal-title":"Prognostic and prediction tools in bladder cancer: A comprehensive review of the literature"},{"key":"10.1016\/j.acuro.2016.12.004_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2009.08.024","article-title":"An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer","volume":"57","author":"Kulkarni**","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","article-title":"Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-016-0466-6","article-title":"Usefulness of pT1 substaging in papillary urothelial bladder carcinoma","volume":"11","author":"Patriarca","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Gu\u00e9rin: Results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero**","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International consultation on bladder cancer 2012: Pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"Van Rhijn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1464-410X.2008.08011.x","article-title":"The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer","volume":"103","author":"Streeper","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2016.12.004_bib0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/00365599.2011.562235","article-title":"Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder","volume":"45","author":"May","year":"2011","journal-title":"Scand J Urol Nephrol [Internet]"},{"key":"10.1016\/j.acuro.2016.12.004_bib0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/00365599.2012.719539","article-title":"Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours","volume":"47","author":"Olsson","year":"2013","journal-title":"Scand J Urol"},{"issue":"6 Suppl 1","key":"10.1016\/j.acuro.2016.12.004_bib0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urology.2005.08.066","article-title":"Management of stage T1 tumors of the bladder: International consensus panel","volume":"66","author":"Nieder*","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2016.12.004_bib0245","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jjco\/hyu119","article-title":"Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: results from a multicenter retrospective study","volume":"4","author":"Nishiyama","year":"2014","journal-title":"Jpn J Clin Oncol."},{"key":"10.1016\/j.acuro.2016.12.004_bib0250","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2016.02.031","article-title":"Papillary recurrence of bladder cancer at first evaluation after induction bacillus Calmette-Gu\u00e9rin therapy: Implication for clinical trial design","volume":"70","author":"Mmeje","year":"2016","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2016.12.004_bib0255","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Gu\u00e9rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: One-third dose versus full dose and 1 year versus 3 years of maintenance","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0260","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.acuro.2015.12.009","article-title":"Estudio retrospectivo de diferentes opciones de tratamiento conservador con bacilo de Calmette-Gu\u00e8rin en el carcinoma urotelial vesical T1G3: terapia de mantenimiento","volume":"40","author":"Palou-Redorta","year":"2016","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2016.12.004_bib0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Gu\u00e9rin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2016.12.004_bib0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.juro.2015.08.075","article-title":"Randomized controlled study of the efficacy, safety and quality of life with low dose bacillus Calmette-Gu\u00e9rin instillation therapy for nonmuscle invasive bladder cancer","volume":"195","author":"Yokomizo","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(02)01920-9","article-title":"Impact of a second transurethral resection on the staging of T1 bladder cancer","volume":"60","author":"Dalbagni","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2016.12.004_bib0280","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/bju.12245","article-title":"Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy","volume":"113","author":"Ark","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2016.12.004_bib0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-410X.2005.05287.x","article-title":"Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy","volume":"95","author":"Wiesner","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2016.12.004_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2012.08.015","article-title":"Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non\u2013muscle invasive bladder cancer: Results from a prospective lymph node mapping study","volume":"32","author":"Bruins HM","year":"2014","journal-title":"Urol Oncol."},{"key":"10.1016\/j.acuro.2016.12.004_bib0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: Results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.12.004_bib0300","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bju.12403","article-title":"Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis","volume":"113","author":"Breau","year":"2014","journal-title":"BJU Int"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617300049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617300049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T12:50:14Z","timestamp":1530017414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480617300049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0210480617300049"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2016.12.004","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indicaci\u00f3n de cistectom\u00eda precoz en el c\u00e1ncer vesical no m\u00fasculo infiltrante. Revisi\u00f3n de la literatura","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}